We're hiring a Post-Graduate Law Fellow to engage in cutting-edge, high-quality research and analysis related to reproductive justice.

If this sounds like you, apply! careers-ucla.icims.com/jobs/1610/job?…

Are you interested in addressing the current national crisis in access to abortion while working towards long-term solutions to advance reproductive justice?

We're hiring for 2 exciting positions UCLA School of Law!

✅Legal and Policy Director
✅Post-Graduate Law Fellow

Apply⤵️

Most pharmacists in California would be willing to prescribe medication abortion in the future, were they legally permitted to do so. Training and attention to pharmacy-level barriers may be needed. ja.ma/4cL1zvr

📢Most pharmacists in California said they were willing to prescribe medication #abortion if that became legal.

▶️ Future training should improve knowledge & confidence in prescribing these drugs 💊

JAMA Network Open #womenshealth

Read more below! 👇
healio.com/news/womens-he…

We're currently hiring for TWO incredible roles at UCLA Law Center on Repro Health, Law, & Policy!

We're looking for an experienced advocate to serve as our first Legal and Policy Director (recruit.apo.ucla.edu/JPF07782), and for a recent grad to be our next Post-Graduate Law Fellow (careers-ucla.icims.com/jobs/1610/job?…).

Thrilled to be an author on UCLA Law Center on Repro Health, Law, & Policy's first article in an academic journal! JAMA Network Open published our study finding that nearly 70% of surveyed CA community pharmacists would be willing to prescribe medication abortion if permitted by law.
jamanetwork.com/journals/jaman…

Today, CRHLP released new research in JAMA Network Open on the willingness of pharmacists to prescribe medication abortion in CA.

The study found that nearly 70% of community pharmacists in CA would be willing to prescribe medication abortion if permitted by law 🧵

We're currently hiring for TWO incredible roles at UCLA Law Center on Repro Health, Law, & Policy!

We're looking for an experienced advocate to serve as our first Legal and Policy Director (recruit.apo.ucla.edu/JPF07782), and for a recent grad to be our next Post-Graduate Law Fellow (careers-ucla.icims.com/jobs/1610/job?…).

🚨We're hiring a Post-Graduate Law Fellow to engage in cutting-edge, high-quality research and analysis related to reproductive justice.

If this sounds like you, apply here: careers-ucla.icims.com/jobs/1610/job?…

'We still have health care deserts across the country, being able to just go directly to the pharmacy and purchase [birth control] is a really amazing opportunity and very important.'

CRHLP staff attorney Cathren Cohen (she/her) in The Christian Science Monitor

csmonitor.com/USA/2024/0403/…

📢Did you hear the news?

We're hiring a Legal and Policy Director!

This is an exciting time to join CRHLP as we continue to set our vision, goals, & priorities.

Learn more and apply by April 5 for full consideration: bit.ly/CRHLP_LPD

Its concerning because reviving Comstock is a key facet of the anti-abortion movement’s strategy for banning abortion nationwide. A future prez administration could interpret & enforce Comstock to ban not only abortion pills, but any instruments related to abortion care. /15

4) Justices expressed concern that courts were second-guessing FDA’s scientific experience. Jessica Ellsworth, representing Danco, noted that plaintiffs’ arguments “would upend not just Mifeprex but virtually every drug approval & REMS modification FDA has made for decades” 13/

3) Telehealth medication abortion is safe, despite plaintiffs’ attempts to claim otherwise. Ps argued that in-person visits with ultrasounds are necessary – but studies and leading medical orgs say that mifepristone can be safely taken w/o an ultrasound or in-person visit. 12/

What plaintiffs are really arguing here – as Justice Jackson pointed out best – is that their ability to conscientiously decline to provide care is not enough, and instead no one should have access to mifepristone because a handful of doctors object to abortion care. 8/

Our team has been listening to and discussing the oral argument in Alliance for Hippocratic Medicine v. FDA all day! Here are our top 5 takeaways:

Though I'm hopeful after today's argument that the Supreme Court will dismiss the mife case, it's important to remember how bonkers it is that this wildly meritless case reached the Supreme Court. The fact that plaintiffs made it this far is a serious problem.

Today, #SCOTUS began hearing oral arguments in AHM v. FDA, a case that challenges the FDA’s suggested prescribing recommendations for mifepristone.

Ushma Upadhyay, PhD, MPH tells UC San Francisco News what you should know about the case and what it could mean for abortion access. ucsf.edu/news/2024/03/4…

Literally shouted “Liar!” a la Legally Blonde at this comment during the live stream.